Analyze Diet
Veterinary microbiology2016; 192; 52-59; doi: 10.1016/j.vetmic.2016.06.012

Equine herpesvirus type 1 modulates inflammatory host immune response genes in equine endothelial cells.

Abstract: Equine herpesvirus myeloencephalopathy (EHM), a disease caused by equine herpesvirus type 1 (EHV-1), is characterized by severe inflammation, thrombosis, and hypoxia in central nervous system (CNS) endothelial cells, which can result in a spectrum of clinical signs including urinary incontinence, ataxia, and paralysis. Strains of EHV-1 that contain a single point mutation within the viral DNA polymerase (nucleotide A2254>G2254: amino acid N752→D752) are isolated from EHM afflicted horses at higher frequencies than EHV-1 strains that do not harbor this mutation. Due to the correlation between the DNA Pol mutation and EHM disease, EHV-1 strains that contain the mutation have been designated as neurologic. In this study, we measured virus replication, cell to cell spread efficacy, and host inflammatory responses in equine endothelial cells infected with 12 different strains of EHV-1. Two strains, T953 (Ohio 2003) (neurologic) and Kentucky A (KyA) (non-neurologic), have well described disease phenotypes while the remaining strains used in this study are classified as neurologic or non-neurologic based solely on the presence or absence of the DNA pol mutation, respectively. Results show that the neurologic strains do not replicate better or spread more efficiently in endothelial cells. Also, the majority of the host inflammatory genes were modulated similarly regardless of EHV-1 genotype. Analyses of host gene expression showed that a subset of pro-inflammatory cytokines, including the CXCR3 ligands CXCL9, CXCL10, and CXCL11, as well as CCL5, IL-6 and TNF-α were consistently up-regulated in endothelial cells infected with each EHV-1 strain. The identification of specific pro-inflammatory cytokines in endothelial cells that are modulated by EHV-1 provides further insight into the factors that contribute to the immunopathology observed after infection and may also reveal new targets for disease intervention.
Publication Date: 2016-06-25 PubMed ID: 27527764DOI: 10.1016/j.vetmic.2016.06.012Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates how Equine herpesvirus type 1 (EHV-1), which causes a disease in horses known as Equine herpesvirus myeloencephalopathy (EHM), interacts with the horse’s immune response. It finds that the virus alters the behavior of certain inflammatory response genes, which could be key to how the disease develops and how it could be treated.

Background

  • EHM causes severe inflammation, thrombosis and hypoxia in the central nervous system (CNS) of horses, leading to symptoms like urinary incontinence, ataxia, and paralysis.
  • Some strains of EHV-1 contain a single point mutation in the viral DNA polymerase, and these variants are found more frequently in horses with EHM.
  • Because of this correlation, EHV-1 strains with the DNA polymerase mutation are categorized as “neurologic”.

Methods and Findings

  • The research investigates the differences between EHV-1 strains by infecting equine endothelial cells with 12 different types, two of which have well-documented disease phenotypes and the remaining ten being classified based on the presence or absence of the DNA polymerase mutation.
  • They found that the “neurologic” strains do not replicate or spread more efficiently in endothelial cells than other types of the virus.
  • The majority of host inflammatory genes responded similarly regardless of the EHV-1 genotype. A subset of pro-inflammatory cytokines, including the CXCR3 ligands CXCL9, CXCL10, and CXCL11, CCL5, IL-6 and TNF-α, consistently showed increased expression in infected endothelial cells.

Implications and Conclusion

  • The study provides new insights into how EHV-1 affects the host’s immune response, with implications for understanding the pathology of EHM.
  • The researchers suggest that the specific pro-inflammatory cytokines that are modulated by EHV-1 could be targets for disease intervention and potential therapeutic strategies.

Cite This Article

APA
Johnstone S, Barsova J, Campos I, Frampton AR. (2016). Equine herpesvirus type 1 modulates inflammatory host immune response genes in equine endothelial cells. Vet Microbiol, 192, 52-59. https://doi.org/10.1016/j.vetmic.2016.06.012

Publication

ISSN: 1873-2542
NlmUniqueID: 7705469
Country: Netherlands
Language: English
Volume: 192
Pages: 52-59
PII: S0378-1135(16)30167-5

Researcher Affiliations

Johnstone, Stephanie
  • Department of Biology and Marine Biology, University of North Carolina Wilmington, 601S. College Rd., Wilmington, NC 28403, USA.
Barsova, Jekaterina
  • Department of Biology and Marine Biology, University of North Carolina Wilmington, 601S. College Rd., Wilmington, NC 28403, USA.
Campos, Isabel
  • Department of Biology and Marine Biology, University of North Carolina Wilmington, 601S. College Rd., Wilmington, NC 28403, USA.
Frampton, Arthur R
  • Department of Biology and Marine Biology, University of North Carolina Wilmington, 601S. College Rd., Wilmington, NC 28403, USA. Electronic address: framptona@uncw.edu.

MeSH Terms

  • Animals
  • Cell Line
  • Endothelial Cells / metabolism
  • Endothelial Cells / virology
  • Gene Expression Regulation / physiology
  • Herpesvirus 1, Equid / physiology
  • Horses
  • Inflammation / metabolism
  • Rabbits
  • Viral Plaque Assay
  • Virus Replication

Citations

This article has been cited 7 times.
  1. Black JB, Frampton AR. Anti-inflammatory compounds reduce equine herpesvirus type 1 replication and cell-to-cell spread. Front Vet Sci 2023;10:1165917.
    doi: 10.3389/fvets.2023.1165917pubmed: 37275614google scholar: lookup
  2. Hu Y, Jia Q, Liu J, Sun W, Bao Z, Che C, Wu G, Fan B, Jarhen, Ran D. Molecular characteristics and pathogenicity of an equid alphaherpesvirus 1 strain isolated in China. Virus Genes 2022 Aug;58(4):284-293.
    doi: 10.1007/s11262-022-01910-ypubmed: 35567668google scholar: lookup
  3. Zarski LM, Weber PSD, Lee Y, Soboll Hussey G. Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection. Pathogens 2021 Jan 7;10(1).
    doi: 10.3390/pathogens10010043pubmed: 33430330google scholar: lookup
  4. Zhang YQ, Gao XX. Association of RANTES gene polymorphisms with susceptibility to childhood asthma: A meta-analysis. Medicine (Baltimore) 2020 Jul 17;99(29):e20953.
    doi: 10.1097/MD.0000000000020953pubmed: 32702834google scholar: lookup
  5. Oladunni FS, Horohov DW, Chambers TM. EHV-1: A Constant Threat to the Horse Industry. Front Microbiol 2019;10:2668.
    doi: 10.3389/fmicb.2019.02668pubmed: 31849857google scholar: lookup
  6. Lessiak U, Melchert M, Walter I, Kummer S, Nell B, Tschulenk W, Pratscher B. Isolation-protocol, characterization, and in-vitro performance of equine umbilical vein endothelial cells. Front Vet Sci 2024;11:1421946.
    doi: 10.3389/fvets.2024.1421946pubmed: 39411390google scholar: lookup
  7. Finding EJT, Faulkner A, Nash L, Wheeler-Jones CPD. Equine Endothelial Cells Show Pro-Angiogenic Behaviours in Response to Fibroblast Growth Factor 2 but Not Vascular Endothelial Growth Factor A. Int J Mol Sci 2024 May 30;25(11).
    doi: 10.3390/ijms25116017pubmed: 38892205google scholar: lookup